This randomized clinical trial compares the effect of continuous positive airway pressure or high-flow nasal oxygen vs conventional oxygen therapy on clinical outcomes in hospitalized patients with COVID-19 and acute hypoxemic respiratory failure (AHRF).
Source: JAMA Online First